Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal PET studies: an example with cell proliferation, glucose transporter 1 and FDG.
OBJECTIVE
To highlight the use of automatic quantification of immunochemical staining on digitized images of whole tumor sections in preclinical positron emission tomography (PET) studies.


METHODS
Xenografted human testicular tumors (36) were imaged with 2-deoxy-2[F-18]fluoro-D: -glucose (FDG) small animal PET (SA-PET). Tumor cell proliferation and glucose transportation were assessed with cyclin A and Glut-1 immunostaining. Tumor slides were digitized and processed with PixCyt software enabling whole slide quantification, then compared with junior and senior pathologist manual scoring. Manual and automatic quantification results were correlated to FDG uptake.


RESULTS
For cyclin A, inter- and intra-observer agreement for manual scoring was 0.52 and 0.72 and concordance between senior pathologist and automatic quantification was 0.84. Correlations between Tumor/Background ratio and tumor cell proliferation assessed by automatic quantification, junior and senior pathologists were 0.75, 0.55, and 0.61, respectively. Correlation between Tumor/Background ratio and Glut-1 assessed by automatic quantification was 0.74.


CONCLUSIONS
Automatic quantification of immunostaining is a valuable tool to overcome inter- and intra-observer variability for correlation of cell proliferation or other markers with tumor tracer uptake.
GRECAN, EA 1772, François Baclesse Comprehensive Cancer Center and Caen University, Caen, France. n.aide@baclesse.fr
Nicolas
N
Aide
Alexandre
A
Labiche
Paulette
P
Herlin
Maria
M
Paciencia
Laurent
L
Poulain
Soizic
S
Dutoit
Françoise
F
Montravers
Pascal
P
Gauduchon
Jacques
J
Chasle
D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019925:Cyclin A / Q000378:metabolism; D019788:Fluorodeoxyglucose F18; D051272:Glucose Transporter Type 1 / Q000378:metabolism*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D049268:Positron-Emission Tomography / Q000379:methods*; D051381:Rats; D023041:Xenograft Model Antitumor Assays
D019925:Cyclin A; D051272:Glucose Transporter Type 1; D019788:Fluorodeoxyglucose F18